TYK Medicines, Inc - B - H Shares Stock: price and insider trades · Hong Kong
1 insider bought €546k of shares over the last 90 days, the latest by WU Yusheng, filed 17 Sept 2026.
TYK Medicines, Inc - B - H Shares: what insiders have been doing
Every trade that managers of TYK Medicines, Inc - B - H Shares disclose to HKEX is tracked on this page. The company sits in the Health Care sector. 1 insider has disclosed 7 filings since 22 October 2025.
Not one open-market sale was filed. On the buying side, 1 insider reported 7 purchases totalling €546k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Those buying include 1 senior executive. At €133k, the purchase published on 9 September 2026 by WU Yusheng is the largest of the period.
The clock since the last published purchase (17 September 2026) now reads 52 days. Filings reach the HKEX feed a median of 1 day after the trade. That lag is the time during which only the insider knows about the trade.
With 7 filings in twelve months, the company is more active than the median of 4 filings across the 1,314 companies we follow on the same exchange. The full history, which starts in 2026, counts 7 purchases against no sales.
For comparison within the same sector, see the insider buying recorded at UCB. This summary is built from HKEX disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleSince the insiders bought
- +1.1%Entry HK$3.26 · Close 21 Oct 2026 HK$3.29
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
- 120,000 shares@ HK$3.4868.5% of flowShareXHKGHKEX:DA20260917E00139Canonical exit: 15 Dec 2026 (T+90)
- 250,000 shares@ HK$3.49717.7% of flowShareXHKGHKEX:DA20260916E00312Canonical exit: 14 Dec 2026 (T+90)
- 400,000 shares@ HK$2.815722.7% of flowShareXHKGHKEX:DA20260915E00211Canonical exit: 13 Dec 2026 (T+90)
- 170,000 shares@ HK$2.70369.2% of flowShareXHKGHKEX:DA20260914E00072Canonical exit: 10 Dec 2026 (T+90)
- 225,000 shares@ HK$2.969913.4% of flowShareXHKGHKEX:DA20260911E00266Canonical exit: 9 Dec 2026 (T+90)
- 60,000 shares@ HK$3.45134.2% of flowShareXHKGHKEX:DA20260910E00121Canonical exit: 8 Dec 2026 (T+90)
- 350,000 shares@ HK$3.462624.3% of flowShareXHKGHKEX:DA20260909E00058Canonical exit: 7 Dec 2026 (T+90)
7 of 7 declarations
About TYK Medicines, Inc - B - H Shares
TYK Medicines, Inc - B - H Shares is a company focused on drug development. It emphasizes innovation in the pharmaceutical sector.
